The TRH test in patients wih borderline personality disorder

Psychiatry Research
J C GarbuttA J Prange

Abstract

Fifteen patients with a primary diagnosis of borderline personality disorder were studied with the thyrotropin-releasing hormone (TRH) test. Twelve carried the additional diagnosis of depression, substance abuse, or both. A blunted thyroid-stimulating hormone (TSH) response to TRH was found in seven patients, two of whom were neither depressed nor had the additional diagnosis of depression and/or substance abuse. TSH blunting was unrelated to such factors as thyroid status, serum cortisol, weight, height, or body surface. Since TSH blunting occurs in about 25% of patients with major depression but not in schizophrenia, the findings suggest that some patients with borderline personality disorder share a neuroendocrine abnormality with some affective disorder patients.

References

Jan 1, 1978·The American Journal of Psychiatry·D J KupferR F Ulrich
Jun 1, 1973·Biochemical Medicine·H C CampuzanoS M Horvath
Aug 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·P HwangH Friesen
Jul 1, 1982·Archives of General Psychiatry·A W LorangerE H Tulis
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON

❮ Previous
Next ❯

Citations

Feb 26, 2000·Depression and Anxiety·H W KoenigsbergL J Siever
Jan 1, 1992·European Archives of Psychiatry and Clinical Neuroscience·B SchloteK H Usadel
Aug 15, 1993·Biological Psychiatry·R J KavoussiL J Siever
Jan 1, 1984·Journal of Psychiatric Research·S Radouco-ThomasC Radouco-Thomas
Jan 1, 1987·Physiology & Behavior·R V RialJ Tur
Jun 1, 1985·Psychiatry Research·S C SchulzR O Friedel
Dec 1, 1985·Psychiatry Research·T SunderlandR M Cohen
Dec 1, 1989·Psychiatry Research·R YehudaE L Giller
Jan 1, 1988·Progress in Neuro-psychopharmacology & Biological Psychiatry·P T Loosen
Jan 1, 1986·Psychoneuroendocrinology·P T LoosenA Tipermas
Dec 1, 1994·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·P P HubainP Linkowski
May 24, 2001·Progress in Neuro-psychopharmacology & Biological Psychiatry·L StanerJ P Macher
Aug 1, 1996·Acta Psychiatrica Scandinavica·P O AlmL Lidberg
Aug 9, 2002·Journal of Affective Disorders·Tarek AsaadAhmed Okasha
Jul 1, 1987·Comprehensive Psychiatry·R D AlarconP A Rippetoe
Sep 1, 1996·Biological Psychiatry·J M De la Fuente, J Mendlewicz
Nov 1, 1987·Acta Psychiatrica Scandinavica·V KontaxakisC Stefanis
Jul 11, 1991·Clinical EEG (electroencephalography)·M E DrakeA Pakalnis
Jan 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·A S KaplanG M Brown
Aug 1, 1991·The British Journal of Psychiatry : the Journal of Mental Science·E S PaykelR Horton
Sep 8, 2016·Harvard Review of Psychiatry·Anthony C Ruocco, Dean Carcone
Jun 1, 1988·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·M SteinerM Korzekwa
Dec 1, 2018·Neuroscience and Biobehavioral Reviews·Elisa DrewsArnoud Arntz
May 1, 1991·Journal of the American Academy of Child and Adolescent Psychiatry·S KutcherM Katic

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.